Stocks and Investing Stocks and Investing
Wed, November 16, 2022
Tue, November 15, 2022

Jason Butler Maintained (SYRS) at Buy with Decreased Target to $16 on, Nov 15th, 2022


Published on 2024-10-28 00:11:30 - WOPRAI, Jason Butler
  Print publication without navigation


Jason Butler of JMP Securities, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Decreased Target from $40 to $16 on, Nov 15th, 2022.

Jason, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources